0.2199

2.14% -0.0048

After Hours: .2165 -0.0034 -1.55%

Azitra Inc (AZTR)

Overview News Price History Discussions Forecast

Azitra Inc stock is currently priced at $0.2199, with a 24-hour trading volume of 324.69K. It has seen a -2.14% decreased in the last 24 hours and a +1.62% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.2215 pivot point. If it approaches the $0.2132 support level, significant changes may occur.

Previous Close:

$0.2247

Open:

$0.22

24h Volume:

324.69K

Market Cap:

$6.33M

Revenue:

$686.00K

Net Income/Loss:

$-11.28M

P/E Ratio:

-0.0713

EPS:

-3.0856

Net Cash Flow:

$-7.68M

1W Performance:

-0.09%

1M Performance:

+1.62%

6M Performance:

-85.81%

1Y Performance:

+0.00%

1D Range:

$0.215

$0.2281

52W Range:

$0.1605

$2.28

Azitra Inc Stock (AZTR) Company Profile

Name

Azitra Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

203 646 6446

Address

21 Business Park Drive, Branford

Employee

Twitter

Next Earnings Date

Latest SEC Filings

AZTR's Discussions on Twitter

Azitra Inc Stock (AZTR) Latest News

Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying

Benzinga

Dow Edges Higher; QuidelOrtho Shares Plummet

Benzinga

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Crude Oil Moves Lower; Louisiana-Pacific Posts Upbeat Earnings

Benzinga

Nasdaq Gains 100 Points; Kraft Heinz Sales Miss Views

Benzinga

Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Benzinga

Azitra Inc Stock (AZTR) Financials Data

Azitra Inc (AZTR) Revenue 2024

AZTR reported a revenue (TTM) of $686.00 thousand for the quarter ending December 31, 2023, a +141.55% rise year-over-year.

Azitra Inc (AZTR) Net Income 2024

AZTR net income (TTM) was -$11.28 million for the quarter ending December 31, 2023, a -5.65% decrease year-over-year.

Azitra Inc (AZTR) Cash Flow 2024

AZTR recorded a free cash flow (TTM) of -$7.68 million for the quarter ending December 31, 2023, a +11.62% increase year-over-year.

Azitra Inc (AZTR) Earnings per Share 2024

AZTR earnings per share (TTM) was -$2.985 for the quarter ending December 31, 2023, a -168.24% decline year-over-year.

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.